Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-05-31 Harris Erik Director Grant or award +5,967 17,052
2024-05-31 Harris Erik Director Grant or award · Stock Option (right to buy) +17,901 17,901
2023-06-01 Harris Erik Director Grant or award +4,216 11,085
2023-06-01 Harris Erik Director Grant or award · Stock Option (right to buy) +12,649 12,649
2022-02-03 Harris Erik Director Grant or award +6,869 6,869
2022-02-03 Harris Erik Director Grant or award · Stock Option (right to buy) +20,607 20,607

Page 1 of 1 · 6 trades